Trial intelligence / Profile preview

Effectiveness of Azunol gargling methods to prevent chemotherapy-induced oral mucositis

jRCT1021260004Recruiting

Start
May 2026
Modality
Small Molecules
Countries
1
01

Overview

Trial of sodium gualenate in stomatitis (2 arms). Primary endpoint: Incidence of grade ≥2 oral mucositis (CTCAE v3.0). Started May 2026; status: recruiting.

02

Drugs

sodium gualenate
03

Conditions

stomatitis

Beyond the preview

Go deeper on jRCT1021260004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1021260004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call